Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Inventory Average (2021 - 2025)

Historic Inventory Average for GeneDx Holdings (WGS) over the last 5 years, with Q3 2025 value amounting to $11.3 million.

  • GeneDx Holdings' Inventory Average rose 668.03% to $11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year increase of 668.03%. This contributed to the annual value of $9.7 million for FY2024, which is 1343.46% down from last year.
  • As of Q3 2025, GeneDx Holdings' Inventory Average stood at $11.3 million, which was up 668.03% from $12.3 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Inventory Average high stood at $42.9 million for Q3 2022, and its period low was $9.1 million during Q4 2023.
  • Moreover, its 5-year median value for Inventory Average was $12.3 million (2025), whereas its average is $20.5 million.
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 4224.07% in 2022, then tumbled by 7565.7% in 2023.
  • Over the past 5 years, GeneDx Holdings' Inventory Average (Quarter) stood at $32.3 million in 2021, then fell by 10.51% to $28.9 million in 2022, then tumbled by 68.66% to $9.1 million in 2023, then rose by 18.17% to $10.7 million in 2024, then rose by 5.05% to $11.3 million in 2025.
  • Its Inventory Average stands at $11.3 million for Q3 2025, versus $12.3 million for Q2 2025 and $11.7 million for Q1 2025.